Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.25.1 (
proteasome
)
28,817
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We have identified a novel 200 kDa nuclear protein that activates the
proteasome
. The protein, which we call
PA200
, has been purified to homogeneity from bovine testis and has been shown to activate proteasomal hydrolysis of peptides, but not proteins. Following gamma-irradiation of HeLa cells the uniform nuclear distribution of
PA200
changes to a strikingly punctate pattern, a behavior characteristic of many DNA repair proteins. Homologs of
PA200
are present in worms, plants and yeast. Others have shown that mutation of yeast
PA200
results in hypersensitivity to bleomycin, and exposure of yeast to DNA damaging agents induces the
PA200
message. Taken together, these findings implicate
PA200
in DNA repair, possibly by recruiting proteasomes to double strand breaks.
...
PMID:PA200, a nuclear proteasome activator involved in DNA repair. 1209 52
We have identified repeat motifs in the large
proteasome
-binding proteins
PA200
and Ecm29 by applying a sensitive sequence profile method. These repeat motifs, especially those of
PA200
, resemble HEAT/ARM repeats in length and other properties but differ from them in the occupancy of certain positions. The HEAT motif consists of two alpha-helices and two turns: molecular modeling suggests that in the
PA200
and Ecm29 repeats, the alpha-helices may be slightly turned relative to their orientations in typical HEAT repeats. Both
PA200
and Ecm29 are composed almost entirely of such repeats, and therefore are likely to have alpha-helical solenoid structures. These observations lead us to speculate on how
PA200
and Ecm29 may associate with proteasomes.
...
PMID:New HEAT-like repeat motifs in proteins regulating proteasome structure and function. 1509 83
Proteasomes perform the majority of proteolysis that occurs in the cytosol and nucleus of eukaryotic cells and, thereby, perform crucial roles in cellular regulation and homeostasis. Isolated proteasomes are inactive because substrates cannot access the proteolytic sites. PA28 and
PA200
are activators that bind to proteasomes and stimulate the hydrolysis of peptides. Several protein inhibitors of the
proteasome
have also been identified, and the properties of these activators and inhibitors have been characterized biochemically. By contrast, their physiological roles--which have been reported to include production of antigenic peptides,
proteasome
assembly and DNA repair--are controversial. In this article, we briefly review the biochemical data and discuss the possible biological roles of PA28,
PA200
and
proteasome
inhibitors.
...
PMID:Mobilizing the proteolytic machine: cell biological roles of proteasome activators and inhibitors. 1565 75
The major enzyme system catalysing the degradation of intracellular proteins is the
proteasome
system. A central inner chamber of the cylinder-shaped 20 S
proteasome
contains the active site, formed by N-terminal threonine residues. The 20 S proteasomes are extremely inefficient in degrading folded protein substrates and therefore one or two multisubunit 19 S regulatory particles bind to one or both ends of the 20 S
proteasome
cylinder, forming 26 S and 30 S proteasomes respectively. These regulatory complexes are able to bind proteins marked as
proteasome
substrates by prior conjugation with polyubiquitin chains, and initiate their unfolding and translocation into the proteolytic chamber of the 20 S
proteasome
, where they are broken down into peptides of 3-25 amino acids. The polyubiquitin tag is removed from the substrate protein by the deubiquitinating activity of the 19 S regulator complex. Under conditions of an intensified immune response, many eukaryotic cells adapt by replacing standard 20 S proteasomes with immuno-proteasomes and/or generating the
proteasome
activator complex, PA28. Both of these adaptations change the protein-breakdown process for optimized generation of antigenic peptide epitopes that are presented by the class I MHCs. Hybrid proteasomes (19 S regulator-20 S
proteasome
-PA28) may have a special function during the immune response. The functions of other
proteasome
accessory complexes, such as
PA200
and PI31 are still under investigation.
...
PMID:Proteasomes. 1625 Aug 96
PA200
, the most recently discovered activator of the 20S
proteasome
, is a nuclear protein thought to play a role in DNA repair. Homologs of
PA200
have been found in rat, frog, birds, worms, and budding yeast, where it is called Blm3p (now known as Blm10p), but not in Drosophila or fission yeast. Western blots of SDS-PAGE transfers reveal 160 and 200K forms of mammalian
PA200
, and organ surveys demonstrate that the 200K species is highest in testis.
PA200
purified from bovine testis binds the ends of the cylindrical 20S
proteasome
, forming volcano-shaped structures in negatively stained EM images. In vitro assays demonstrate that binding of
PA200
activates peptide hydrolysis by the 20S
proteasome
. This chapter describes the purification and assay of bovine testis
PA200
.
...
PMID:Purification and assay of proteasome activator PA200. 1627 39
The
PA200
proteasome
activator is a broadly expressed nuclear protein. Although how
PA200
normally functions is not fully understood, it has been suggested to be involved in the repair of DNA double-strand breaks (DSBs). The
PA200
gene (Psme4) is composed of 45 coding exons spanning 108 kb on mouse chromosome 11. We generated a
PA200
null allele (
PA200
(Delta)) through Cre-loxP-mediated interchromosomal recombination after targeting loxP sites at either end of the locus.
PA200
(Delta/Delta) mice are viable and have no obvious developmental abnormalities. Both lymphocyte development and immunoglobulin class switching, which rely on the generation and repair of DNA DSBs, are unperturbed in
PA200
(Delta/Delta) mice. Additionally,
PA200
(Delta/Delta) embryonic stem cells do not exhibit increased sensitivity to either ionizing radiation or bleomycin. Thus,
PA200
is not essential for the repair of DNA DSBs generated in these settings. Notably, loss of
PA200
led to a marked reduction in male, but not female, fertility. This was due to defects in spermatogenesis observed in meiotic spermatocytes and during the maturation of postmeiotic haploid spermatids. Thus,
PA200
serves an important nonredundant function during spermatogenesis, suggesting that the efficient generation of male gametes has distinct protein metabolic requirements.
...
PMID:Proteasome activator PA200 is required for normal spermatogenesis. 1658 75
The importance of proteasomes in governing the intracellular protein degradation process has been increasingly recognized. Recent investigations indicate that
proteasome
complexes may exist in a species- and cell-type-specific fashion. To date, despite evidence linking impaired protein degradation to cardiac disease phenotypes, virtually nothing is known regarding the molecular composition, function, or regulation of cardiac proteasomes. We have taken a functional proteomic approach to characterize 26S proteasomes in the murine heart. Multidimensional chromatography was used to obtain highly purified and functionally viable cardiac 20S and 19S
proteasome
complexes, which were subjected to electrophoresis and tandem mass spectrometry analyses. Our data revealed complex molecular organization of cardiac 26S proteasomes, some of which are similar to what were reported in yeast, whereas others exhibit contrasting features that have not been previously identified in other species or cell types. At least 36 distinct subunits (17 of 20S and 19 of 19S) are coexpressed and assembled as 26S proteasomes in this vital cardiac organelle, whereas the expression of
PA200
and 11S subunits were detected with limited participation in the 26S complexes. The 19S subunits included a new alternatively spliced isoform of Rpn10 (Rpn10b) along with its primary isoform (Rpn10a). Immunoblotting and immunocytochemistry verified the expression of key alpha and beta subunits in cardiomyocytes. The expression of 14 constitutive alpha and beta subunits in parallel with their three inducible subunits (beta1i, beta2i, and beta5i) in the normal heart was not expected; these findings represent a distinct level of structural complexity of cardiac proteasomes, significantly different from that of yeast and human erythrocytes. Furthermore, liquid chromatography/tandem mass spectroscopy characterized 3 distinct types of post-translational modifications including (1) N-terminal acetylation of 19S subunits (Rpn1, Rpn5, Rpn6, Rpt3, and Rpt6) and 20S subunits (alpha2, alpha5, alpha7, beta3, and beta4); (2) N-terminal myristoylation of a 19S subunit (Rpt2); and (3) phosphorylation of 20S subunits (eg, alpha7)). Taken together, this report presents the first comprehensive characterization of cardiac 26S proteasomes, providing critical structural and proteomic information fundamental to our future understanding of this essential protein degradation system in the normal and diseased myocardium.
...
PMID:Mapping the murine cardiac 26S proteasome complexes. 1691
The 20 S
proteasome
is regulated at multiple levels including association with endogenous activators. Two activators have been described for the yeast 20 S
proteasome
: the 19 S regulatory particle and the Blm10 protein. The sequence of Blm10 is 20% identical to the mammalian
PA200
protein. Recent studies have shown that the sequences of Blm10 and
PA200
each contain multiple HEAT-repeats and that each binds to the ends of mature proteasomes, suggesting a common structural and biochemical function. In order to advance structural studies, we have developed an efficient purification method that produces high yields of stoichiometric Blm10-mature yeast 20 S
proteasome
complexes and we constructed a three-dimensional (3D) model of the Blm10-20 S complex from cryo-electron microscopy images. This reconstruction shows that Blm10 binds in a defined orientation to both ends of the 20 S particle and contacts all the
proteasome
alpha subunits. Blm10 displays the solenoid folding predicted by the presence of multiple HEAT-like repeats and the axial gates on the alpha rings of the
proteasome
appear to be open in the complex. We also performed a genetic analysis in an effort to identify the physiological role of Blm10. These experiments, however, did not reveal a robust phenotype upon gene deletion, overexpression, or in a screen for synthetic effects. This leaves the physiological role of Blm10 unresolved, but challenges earlier findings of a role in DNA repair.
...
PMID:Structure of the Blm10-20 S proteasome complex by cryo-electron microscopy. Insights into the mechanism of activation of mature yeast proteasomes. 1695 74
Yeast Blm10 and mammalian
PA200
proteins share significant sequence similarity and both cap the ends of 20 S proteasomes and enhance degradation of some peptide substrates. Blm10 was identified as a suppressor of the yeast blm3-1 mutation, and initially was thought to be the Blm3 protein. Both the blm3-1 and blm10-Delta mutations were reported to cause sensitivity to bleomycin and other forms of DNA damage, suggesting a role for Blm10/
PA200
-
proteasome
complexes in DNA repair. We have been unable to observe significant DNA damage sensitivity in blm10-Delta mutants in several genetic backgrounds, and we have therefore further investigated the relationship between BLM10 and blm3-1. We find that blm3-1 is a nonsense mutation in the ubiquitin protease gene UBP3. Deleting UBP3 causes phenotypes similar to those caused by blm3-1, but neither causes a general defect in DNA repair. Ubp3 has several known functions, and genetic interaction data presented here suggest an additional role in transcriptional elongation. The phenotypes caused by blm3-1 and ubp3-Delta mutations are not suppressed by over-expression of BLM10, nor are they affected by deletion of BLM10. These results remove key components of the previously reported connection between Blm10/
PA200
-
proteasome
complexes and DNA repair, and they suggest a novel way to interpret sensitivity to bleomycin as resulting from defects in transcription elongation.
...
PMID:blm3-1 is an allele of UBP3, a ubiquitin protease that appears to act during transcription of damaged DNA. 1699 24
Proteasome activator PA200
enhances
proteasome
-mediated cleavage after acidic residues in vitro; however, its role within cells is not known. Here, we show that, in response to ionizing radiation,
PA200
forms hybrid proteasomes with 19S caps and 20S core proteasomes that accumulate on chromatin, leading to an increase in proteolytic activity. Unlike many other proteins that respond to DNA damage, the response of
PA200
appears to be independent of Ataxia Telangiectasia Mutated and p53, but dependent on DNA-dependent protein kinase activity. Nonetheless,
PA200
is critical because
PA200
-knockdown cells show genomic instability and reduced survival after exposure to ionizing radiation. This phenotype is reproduced by specific inhibition of postglutamyl activity of proteasomes, but combined treatment with
PA200
siRNA and postglutamyl inhibitor does not show additive effects on survival. Together, these data suggest a unique role for
PA200
in genomic stability that is likely mediated through its ability to enhance postglutamyl cleavage by proteasomes.
...
PMID:Role for proteasome activator PA200 and postglutamyl proteasome activity in genomic stability. 1884 80
1
2
3
4
5
Next >>